German biotech company to partner with Rwanda

- Advertisement -

BERLIN (CU)_During the past week, COVID-19 vaccinations in the Africa tripled to 13 million doses as donations of vaccines increased from developed nations. However, this still remains a drop in an ocean in a region home to 1.3 billion people, of which only 2.4 per cent has been vaccinated so far. Therefore, with the aim of setting up a sustainable Coronavirus vaccine manufacturing programme in the African continent, the government officials of Rwanda and Senegal met with the top executives of German biotechnology company BioNTech. The President of the European Commission Ursula von der Leyen also participated in the meeting that was held in Berlin on Friday (27 August).  

BioNTech is well known for its recent collaboration with…

Hot this week

Plants May Soon Have Their Own Health Trackers

Smartwatches track our heart rate, oxygen levels, and sleep....

Aviation Caught in the Storm: Sri Lankan Airlines Suspends Kuwait Flights as Middle East Tensions Escalate

Sri Lankan Airlines has recently taken an unprecedented step...

Could Kenya’s New Tariffs Derail East Africa’s Free Trade Dream?

On the 20th of July, 2026, Goodwill Tanzania Ceramic...

India’s First Dengue Vaccine Approved as QDENGA Gains DCGI Approval

India has approved its first dengue vaccine, marking a...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories